| Identification | Back Directory | [Name]
5-((3aS,4S,6aR)-2-Oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)-N-(2-(2-(2-(prop-2-yn-1-yloxy)ethoxy)ethoxy)ethyl)pentanamide | [CAS]
1421701-68-9 | [Synonyms]
Biotin-PEG3-Alkyne
N-(2-(2-(2-(prop-2-ynyloxy)ethoxy)ethoxy)ethyl)-5-(hexahydro-2-oxo-1H-thieno[3,4-d]imidazol-4-yl)pentanamide
1H-Thieno[3,4-d]imidazole-4-pentanamide, hexahydro-2-oxo-N-[2-[2-[2-(2-propyn-1-yloxy)ethoxy]ethoxy]ethyl]-, (3aS,4S,6aR)-
5-((3aS,4S,6aR)-2-Oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)-N-(2-(2-(2-(prop-2-yn-1-yloxy)ethoxy)ethoxy)ethyl)pentanamide | [Molecular Formula]
C19H31N3O5S | [MDL Number]
MFCD31922734 | [MOL File]
1421701-68-9.mol | [Molecular Weight]
413.53 |
| Hazard Information | Back Directory | [Uses]
Biotin-PEG3-propargyl is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs[1]. Biotin-PEG3-propargyl is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups. | [IC 50]
PEGs | [References]
[1] An S, et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018 Oct;36:553-562 DOI:10.1016/j.ebiom.2018.09.005 |
|
|